Metraipolis › archive › dc_51bb75a4e649

Oral GLP-1-Based Therapeutics in the Obesity-Metabolic Syndrome-Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies — Europe PMC PMID:42198407

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42198407
DOI
10.3390/ph19050732
License (as archived)
solo-consultazione
Archived
2026-11-02T15:54:44.820Z
SHA-256 of the archived text
88441a3c27547969722e7fd7475976b0f83869b0f4ce53669e6b197f46f4aadb
Stable URL of this page
https://metraipolis.com/documento/dc_51bb75a4e649

How to cite

Oral GLP-1-Based Therapeutics in the Obesity-Metabolic Syndrome-Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies — Europe PMC PMID:42198407 — Europe PMC (en), https://europepmc.org/article/MED/42198407 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_51bb75a4e649 (Metraipolis archive dc_51bb75a4e649, sha256 88441a3c27547969722e7fd7475976b0f83869b0f4ce53669e6b197f46f4aadb)
BibTeX
@misc{dc51bb75a4e649,
  title = {Oral GLP-1-Based Therapeutics in the Obesity-Metabolic Syndrome-Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies — Europe PMC PMID:42198407},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42198407},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_51bb75a4e649; sha256 88441a3c27547969722e7fd7475976b0f83869b0f4ce53669e6b197f46f4aadb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42198407. Agents can read the archived copy with the MCP tool read_document.